
|Articles|June 22, 2020
Scientific Outsourcing and Insourcing Solutions
Author(s)Eurofins
Eurofins’ whitepaper discusses insourcing & outsourcing solutions to solve challenges with meeting drug development timelines and budgets with restricted headcounts.
Trending on Pharmaceutical Technology
1
GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing
2
How a 63-Patient Trial Delivered an FDA Approval
3
Ask the Expert: Complying with Standards
4
Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing
5